Practice parameters for detection of colorectal neoplasms

Diseases of the Colon and Rectum

Volumn 42, Issue 9, 1999, Pages 1123-1129

  Simmang, Clifford L ^a   Senatore, Peter ^a   Lowry, Ann ^a   Hicks, Terry ^a   Burnstein, Marcus ^a   Dentsman, Frederick ^a   Fazio, Victor ^a   Glennon, Edward ^a   Hyman, Neil ^a   Kerner, Bruce ^a   Kilkenny, John ^a   Moore, Richard ^a   Peters, Walter ^a   Ross, Theodore ^a   Savoca, Paul ^a   Vernava, Anthony ^a   Wong, W Douglas ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CANCER SCREENING; CLINICAL PROTOCOL; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC APPROACH ROUTE; FAMILY HISTORY; HUMAN; PHYSICAL EXAMINATION; RISK ASSESSMENT; RISK FACTOR; SIGMOIDOSCOPY;

COLONIC POLYPS; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; HUMANS; INFLAMMATORY BOWEL DISEASES; MASS SCREENING; RISK FACTORS;

EID: 0032819818     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02238562     Document Type: Article

References (65)

1. Rosen L, Abel ME, Gordon PH, et al., The American Society of Colon and Rectal Surgeons Standards Task Force. Practice parameters for the detection of colorectal neoplasms - supporting documentation. Dis Colon Rectum 1992;35:391-4.
2. Parker SL, Tong T, Bolden S, Wingo PA, Cancer statistics 1996. CA Cancer J Clin 1996;46:5-27.
3. Nelson RL, Persky V. The rise and fall of colorectal cancer [letter]. Dis Colon Rectum 1994;37:1175-6.
4. National Cancer Institute. Cancer statistics review 1973-1987. Bethesda: National Institute of Health, Publication No. 90-2789. 1990,
5. Ransohoff DF, Lang CA. Current concepts: screening for colorectal cancer. N Engl J Med 1991;325:37-41.
6. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
7. Kewenter J, Bjork S, Haglind E, Smith L, Svanik J, Ahren C. Screening and rescreening for colorectal cancer: a controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 1988;62:645-51.
8. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
9. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993;85:1311-8.
10. Jaramillo E, Slezak P. Comparison between double-contrast barium enema and colonoscopy to investigate lower gastrointestinal bleeding. Gastrointest Radiol 1992;17:81-3.
11. Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991;86:946-51.
12. American Cancer Society. Cancer facts and figures, 1996. Atlanta: American Cancer Society Publication No. 5008-96. 1996.
13. Wagner JL, Tunis S, Brown M, et al. Cost-effectiveness of colorectal cancer screening in average-risk adults. In: Young G, Levin, B, eds. Prevention and early detection of colorectal cancer. London: WB Saunders, 1996.
14. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
15. Hardcastle JD, Thomas WM, Chamberlain J, et al. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet 1989;1:1160-4.
16. Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 1994;29:468-73.
17. Steine S, Stordahl A, Lunde OC, Loken K, Laerum E. Double-contrast barium enema versus colonoscopy in the diagnosis of neoplastic disorders: aspects of decision-making in general practice. Fam Pract 1993;10:288-91.
18. Brewster NP, Grieve DC, Saunders JH. Double-contrast barium enema and flexible sigmoidoscopy for routine colonic investigation. Br J Surg 1994;8:445-7.
19. Winawer SJ, Zauber AG, O'Brien MJ, et al., The National Polyp Study Workgroup. The National Polyp Study. 1. Design, methods and characteristics of patients with newly diagnosed polyps. Cancer 1992;70(Suppl 5):1236-45.
20. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-657.
21. Winawer SJ, Zauber AG, Diaz B. The National Polyp Study: temporal sequence of evolving colorectal cancer from the normal colon [abstract]. Gastrointest Endosc 1987;33:A167.
22. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and risk of colorectal cancer. N Engl J Med 1994;331;1669-74.
23. Cali RL, Pitsch RM, Thorson AG, et al. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 1993;36:388-93.
24. St. John DJ, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993;118:785-90.
25. Strachan JR, Woodhouse CR. Malignancy following ureterosigmoidostomy in patients with exstrophy. Br J Surg 1991;78:1216-8.
26. Badalament RA, Cirulli C, Zerick W, Lucas JG, Drago JR. Colon carcinoma associated with ureterosigmoidostomy. J Surg Oncol 1990;45:207-11.
27. Husmann DA, Spence HM. Current status of tumor of the bowel following ureterosigmoidostomy: a review, J Urol 1990;144:607-10.
28. Ron E, Gridley G, Hrubec Z, Page W, Arora S, Fraumeni JF Jr. Acromegaly and gastrointestinal cancer. Cancer 1991;68:1673-7.
29. Klein RS, Recco RA, Catalane MT, Edberg SC, Casey JI, Steigbigel NH. Association of streptococcus bovis with carcinoma of the colon. N Engl J Med 1977;297:900-2.
30. Macaluso A, Simmang C, Anthony T. Streptococcus sanguis bacteremia and colorectal cancer. South Med J 1998;91:206-7.
31. Lorimer JW, Eidus LB. Invasive Clostridium septicum infection in association with colorectal carcinoma. Can J Surg 1994;37:245-9.
32. Buckley D, Kudsk K. Occult gastrointestinal carcinoma causing metastatic clostridial soft-tissue infection: report of two cases. Dis Colon Rectum 1998;31:306-10.
33. Mohamed AR, Karawi MA, Yasawy Ml. Schistosomal colonic disease. Gut 1990;31:439-42
34. Helwig EB, Graham JH. Anogenital Paget's disease. Cancer 1963;16:387.
35. Schellenberger RR, Burford C, Kune GA. Perianal Paget's disease. Aust N Z J Surg 1988;58:727-32.
36. Herzog U, von Flue M, de Roche R, Curschellas E. Perianal extramammary Paget's disease. Report of two cases. Eur J Surg Oncol 1993;19:469-73.
37. Nyui S, Osanai H, Ohba S, Masuoka H, Yoshida Y. Relapse of colon cancer followed by polymyositis: report of a case and review of the literature. Surg Today 1997;27:559-62.
38. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Engl J Med 1992;326:363-7.
39. Rex DK, Smith JJ, Ulbright TM, Lehman GA. Distal colonic hyperplastic polyps do not predict proximal adenomas in asymptomatic average risk subjects. Gastroenterology 1992;102:317-9.
40. Winawer J, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993:328:901-6.
41. Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps. Ann Intern Med 1993;119:836-43.
42. Cooper HS, Deppisch LM, Gourley WK, et al. Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology 1995;108:1657-65.
43. Jang Y-S, Steinhagen RM, Heimann TM. Colorectal cancer in familial adenomatous polyposis. Dis Colon Rectum 1997;40:312-6.
44. Haggitt RC, Reid BJ. Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol 1986;10:871-7.
45. Lovett E. Family studies in cancer of the colon and rectum. Br J Surg 1976;630:13-8.
46. Fitzsimmons ML. Hereditary colorectal cancers. Semin Oncol Nurs 1992;8:252-7.
47. Bauer WM, Lashner BA. Inflammatory bowel disease and intestinal cancer. Practical Gastroenterol 1998;22:20-7.
48. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population based study. N Engl J Med 1990;323:1228-33.
49. Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH Jr. A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 1981;48:2742-5.
50. Jarrinen HJ. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. Gut 1992;3:357-60.
51. Matsumoto T, lida M, Mibu R, Fujishima M. Risk of cancer development in the rectal remnant of patients with familial adenomatous polyposis/Gardner's syndrome. Hepatogastroenterology 1995;42:765-70.
52. Petersen GM, Boyd PA. Gene tests and counseling for colorectal cancer risk: lessons from familial polyposis. J Natl Cancer Inst Monogr 1995 ;17-.67-71.
53. Mills SJ, Chapman PD, Burn J, Gunn A. Endoscopie screening and surgery for familial adenomatous polyposis: dangerous delays. Br J Surg 1997;84:74-7.
54. Percesepe A, Anti M, Marra G, et al. Role of clinical criteria in the diagnosis of hereditary non-polyposis colorectal cancer (HNPCC): results of a multivariate analysis. Int J Cancer 1994;58:799-802.
55. Vasen HF, Mecklin J-P, Kahn PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
56. Burke W, Petersen G, Lynch P, et al., Cancer Genetics Studies Consortium. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. JAMA 1997;277:915-9.
57. Vasen HF, den Hartog Jager FC, Menko FH, et al. Screening for hereditary nonpolyposis colorectal cancer: a study of 22 kindreds in The Netherlands. Am J Med 1989;86:278-81.
58. Vasen HF, Mecklin JP, Watson P, et al. Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 families. Dis Colon Rectum 1993;36:1-4.
59. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 1994;35:950-4.
60. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990;31:800-6.
61. Greenstein AJ, Sachar DB, Smith H, et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 1979;77:290-4.
62. Lashner BA, Hanauer SB, Silverstein MD. Optimal timing of colonoscopy to screen for cancer in ulcerative colitis. Ann Intern Med 1988;108:274-8.
63. Jewell DP. Ulcerative Colitis. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Gastrointestinal and liver disease. 6th ed. Philadelphia: WB Saunders, 1998:1755.
64. Greenstein AJ, Sugita A, Yamazaki Y. Cancer in inflammatory bowel disease. Surg Today 1989;19:633-44.
65. Cooper DJ, Weinstein MA, Korelitz BI. Complications of Crohn's disease predisposing to dysplasia and cancer of the intestinal tract. Consideration of a surveillance program. J Clin Gastroenterol 1984;6:217-24.